Close
Close
Actinium Receives Positive from EMA for AML
607 views
2.44444444444
2.4 from 9 votes

Executive Chairman of Actinium Pharmaceuticals discusses his company's positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathway for Actinium, an Acute Myeloid Leukemia (AML) drug.

Learn more about:

Access Programs

by Abidemi Uruejoma
28 views 2 weeks ago
by Abidemi Uruejoma
60 views 1 month ago
by Abidemi Uruejoma
78 views 1 month ago
by Abidemi Uruejoma
82 views 2 months ago
by Abidemi Uruejoma
104 views 2 months ago
by Abidemi Uruejoma
110 views 2 months ago
by Abidemi Uruejoma
112 views 2 months ago
by Abidemi Uruejoma
124 views 2 months ago
by Abidemi Uruejoma
111 views 2 months ago
2.44444444444
2.4 from 9 votes
Free Newsletter
Find a Clinical Trial
Related Videos
News Articles